| Survival: | 10.6 months |
| Toxicity Grade: | 4 |
| Treatments: | Chemotherapy |
| Drugs: | Navelbine |
| Country: | United Kingdom |
| City/State/Province: | London |
| Hospital: | St Bartholomew’s Hospital |
| Journal: | Link |
| Date: | 12/2000 |
| Description: |
| Patients: This Phase II study involved 29 patients with malignant pleural mesothelioma. Treatment: The treatment consisted of administration of the chemotherapy drug, vinorelbine (navelbine). Toxicity: Grade 3-4 toxicities included neutropenia, leucopenia, constipation, and phlebitis Results: The median overall survival from the time of first treatment was 10.6 months. Support: The authors of the study acknowledged the support of Pierre-Fabre Oncology for subsidized drug costs. Correspondence: Jeremy P.C. Steele, MD |